关注
Dr. Shaan Dudani
Dr. Shaan Dudani
Medical Oncologist
在 williamoslerhs.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival
S Dudani, G De Velasco, JC Wells, CL Gan, F Donskov, C Porta, ...
JAMA network open 4 (1), e2021869-e2021869, 2021
1622021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ...
Nature communications 12 (1), 808, 2021
1102021
First-line immuno-oncology combination therapies in metastatic renal-cell carcinoma: results from the international metastatic renal-cell carcinoma database consortium
S Dudani, J Graham, JC Wells, Z Bakouny, SK Pal, N Dizman, F Donskov, ...
European urology 76 (6), 861-867, 2019
792019
Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
S Abou Alaiwi, W Xie, AH Nassar, S Dudani, D Martini, Z Bakouny, ...
Journal for ImmunoTherapy of Cancer 8 (1), 2020
752020
Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: an observational study from the …
Z Bakouny, T El Zarif, S Dudani, JC Wells, CL Gan, F Donskov, J Shapiro, ...
European urology 83 (2), 145-151, 2023
722023
Prognostication in kidney cancer: recent advances and future directions
J Graham, S Dudani, DYC Heng
Journal of Clinical Oncology 36 (36), 3567-3573, 2018
702018
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Z Bakouny, A Sadagopan, P Ravi, NY Metaferia, J Li, S AbuHammad, ...
Cell reports 38 (1), 2022
652022
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant …
S Dudani, H Marginean, PA Tang, JG Monzon, S Raissouni, TR Asmis, ...
BMC cancer 19, 1-9, 2019
552019
Optimal management of leptomeningeal carcinomatosis in breast cancer patients—a systematic review
S Dudani, S Mazzarello, J Hilton, B Hutton, L Vandermeer, R Fernandes, ...
Clinical Breast Cancer 16 (6), 456-470, 2016
352016
Point of care molecular testing: community-based rapid next-generation sequencing to support cancer care
BS Sheffield, A Beharry, J Diep, K Perdrizet, MAJ Iafolla, W Raskin, ...
Current Oncology 29 (3), 1326-1334, 2022
322022
An update on predictive biomarkers in metastatic renal cell carcinoma
S Dudani, MF Savard, DYC Heng
European Urology Focus 6 (1), 34-36, 2020
312020
Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic …
CL Gan, S Dudani, JC Wells, F Donskov, SK Pal, N Dizman, N Rathi, ...
Cancer Medicine 10 (4), 1212-1221, 2021
302021
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials
CL Gan, I Stukalin, DE Meyers, S Dudani, HAI Grosjean, S Dolter, ...
European Journal of Cancer 151, 115-125, 2021
292021
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
R Fernandes, S Mazzarello, C Stober, L Vandermeer, S Dudani, ...
Breast cancer research and treatment 161, 1-10, 2017
282017
Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): a propensity score-based …
Z Bakouny, W Xie, S Dudani, C Wells, CL Gan, F Donskov, J Shapiro, ...
Journal of Clinical Oncology 38 (6_suppl), 608-608, 2020
242020
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy
J Graham, JC Wells, S Dudani, CL Gan, F Donskov, J Lee, ...
European Journal of Cancer 171, 124-132, 2022
232022
Assessment of immune checkpoint inhibitors and genomic alterations by body mass index in advanced renal cell carcinoma
AKA Lalani, Z Bakouny, S Farah, F Donskov, S Dudani, DYC Heng, ...
JAMA oncology 7 (5), 773-775, 2021
222021
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
E Hasanov, DN Yeboa, MD Tucker, TA Swanson, TH Beckham, B Rini, ...
CA: A Cancer Journal for Clinicians 72 (5), 454-489, 2022
212022
Sites of Metastasis and Survival in Metastatic Renal-Cell Carcinoma (mRCC)
S Dudani, J Guillermo de Velasco, CL Gan, F Donskov, C Porta, ...
Europe 3474 (10,320), 34, 2020
212020
Real‐world assessment of clinical outcomes among first‐line sunitinib patients with clear cell metastatic renal cell carcinoma (mRCC) by the international mRCC database …
MF Savard, JC Wells, J Graham, S Dudani, JA Steinharter, BA McGregor, ...
The Oncologist 25 (5), 422-430, 2020
182020
系统目前无法执行此操作,请稍后再试。
文章 1–20